English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

End-stage heart failure is a growing problem associated with high mortality, using conventional medical care.1 Although heart transplantation remains the gold standard therapy for end-stage heart failure, it is a limited resource that is not applicable to a large portion of heart failure patients, particularly the elderly. An alternative strategy for patients who do not meet standard heart transplantation criteria is destination therapy with left ventricular assist device (LVAD) implantation.2 The implantation of nonpulsatile, continuous-flow LVADs has become a relatively routine procedure in large surgical centers that is associated with a relatively low complication rate.3 However, cannulation for LVAD implantation is occasionally challenging. In particular, patients who have undergone a LV restoration and patch volume reduction plasty (ie, “Dor procedure”)4 pose a particular challenge. We describe a favorable 1-year outcome for a severely symptomatic patient with chronic ischemic heart failure and a large LV aneurysm treated by a Dor procedure and simultaneous LVAD implantation.### Patient PresentationA 52-year-old patient with ischemic heart failure was referred to our institution for further therapy and possible evaluation for heart transplantation. His medical history was pertinent for heart failure and multiple stenting of the left anterior descending artery. The …

Combined Surgical Left Ventricular Reconstruction and Left Ventricular Assist Device Implantation for Destination Therapy in End-Stage Heart Failure